NEW YORK (GenomeWeb News) – Luminex announced after the close of the market Wednesday that Life Technologies will sell and distribute the firm's Magpix instrument worldwide.
Magpix, which was launched last year, is a compact multiplex analyzer that rapidly detects 50 different analytes simultaneously on a single sample, including proteins and nucleic acids. The system is based on Luminex's xMAP technology and provides nearly 5,000 data points in under an hour.
"Magpix represents a unique platform through which Life Technologies can make its cutting-edge antibody content accessible for a broad range of protein quantitation needs in basic and clinical research," Peter Dansky, president of molecular and cell biology at Life Technologies, said in a statement.
Financial and other terms of the agreement were not disclosed.